HomeRCKT • NASDAQ
add
Rocket Pharmaceuticals Inc
Previous close
$22.10
Day range
$21.70 - $22.30
Year range
$14.89 - $32.53
Market cap
1.99B USD
Avg Volume
699.14K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 63.28M | -3.22% |
Net income | -59.66M | 10.59% |
Net profit margin | — | — |
Earnings per share | -0.64 | 28.09% |
EBITDA | -61.34M | 3.55% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 373.18M | 4.71% |
Total assets | 566.34M | 2.63% |
Total liabilities | 73.77M | 18.75% |
Total equity | 492.57M | — |
Shares outstanding | 90.50M | — |
Price to book | 4.05 | — |
Return on assets | -27.16% | — |
Return on capital | -29.19% | — |
Cash Flow
Net change in cash
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Net income | -59.66M | 10.59% |
Cash from operations | -29.34M | 47.63% |
Cash from investing | -140.80M | -29.67% |
Cash from financing | 391.00K | -99.64% |
Net change in cash | -169.75M | -202.23% |
Free cash flow | -12.81M | 52.40% |
About
Founded
1999
Website
Employees
268